Literature DB >> 21998402

Impaired expression of the inducible cAMP early repressor accounts for sustained adipose CREB activity in obesity.

Dimitri Favre1, Eric Le Gouill, Denis Fahmi, Chantal Verdumo, Giulia Chinetti-Gbaguidi, Bart Staels, Robert Caiazzo, François Pattou, Kim-Anne Lê, Luc Tappy, Romano Regazzi, Vittorio Giusti, Peter Vollenweider, Gérard Waeber, Amar Abderrahmani.   

Abstract

OBJECTIVE: Increase in adipose cAMP-responsive element binding protein (CREB) activity promotes adipocyte dysfunction and systemic insulin resistance in obese mice. This is achieved by increasing the expression of activating transcription factor 3 (ATF3). In this study, we investigated whether impaired expression of the inducible cAMP early repressor (ICER), a transcriptional antagonist of CREB, is responsible for the increased CREB activity in adipocytes of obese mice and humans. RESEARCH DESIGN AND METHODS: Total RNA and nuclear proteins were prepared from visceral adipose tissue (VAT) of human nonobese or obese subjects and white adipose tissue (WAT) of C57Bl6-Rj mice that were fed with normal or high-fat diet for 16 weeks. The expression of genes was monitored by real-time PCR, Western blotting, and electromobility shift assays. RNA interference was used to silence the expression of Icer.
RESULTS: The expression of Icer/ICER was reduced in VAT and WAT of obese humans and mice, respectively. Diminution of Icer/ICER was restricted to adipocytes and was accompanied by a rise of Atf3/ATF3 and diminution of Adipoq/ADIPOQ and Glut4/GLUT4. Silencing the expression of Icer in 3T3-L1 adipocytes mimicked the results observed in human and mice cells and hampered glucose uptake, thus confirming the requirement of Icer for appropriate adipocyte function.
CONCLUSIONS: Impaired expression of ICER contributes to elevation in CREB target genes and, therefore, to the development of insulin resistance in obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998402      PMCID: PMC3219947          DOI: 10.2337/db10-1743

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.

Authors:  E D Abel; O Peroni; J K Kim; Y B Kim; O Boss; E Hadro; T Minnemann; G I Shulman; B B Kahn
Journal:  Nature       Date:  2001-02-08       Impact factor: 49.962

2.  Extraction of total RNA from adipocytes.

Authors:  J Janke; S Engeli; K Gorzelniak; A M Sharma
Journal:  Horm Metab Res       Date:  2001-04       Impact factor: 2.936

3.  Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.

Authors:  Sarah R Preis; Joseph M Massaro; Sander J Robins; Udo Hoffmann; Ramachandran S Vasan; Thomas Irlbeck; James B Meigs; Patrice Sutherland; Ralph B D'Agostino; Christopher J O'Donnell; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-03-25       Impact factor: 5.002

4.  CREB activation induces adipogenesis in 3T3-L1 cells.

Authors:  J E Reusch; L A Colton; D J Klemm
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase.

Authors:  H Duplain; R Burcelin; C Sartori; S Cook; M Egli; M Lepori; P Vollenweider; T Pedrazzini; P Nicod; B Thorens; U Scherrer
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

6.  The expression of inducible cAMP early repressor (ICER) is altered in prostate cancer cells and reverses the transformed phenotype of the LNCaP prostate tumor cell line.

Authors:  G Yehia; R Razavi; E Memin; F Schlotter; C A Molina
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

7.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.

Authors:  K Hotta; T Funahashi; N L Bodkin; H K Ortmeyer; Y Arita; B C Hansen; Y Matsuzawa
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

8.  Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.

Authors:  A Peri; B Conforti; S Baglioni-Peri; P Luciani; F Cioppi; L Buci; S Corbetta; E Ballaré; M Serio; A Spada
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

9.  Expression of peroxisome proliferator-activated receptor-gamma1 and peroxisome proliferator-activated receptor-gamma2 in visceral and subcutaneous adipose tissue of obese women.

Authors:  Vittorio Giusti; Chantal Verdumo; Michel Suter; Rolf Christian Gaillard; Peter Burckhardt; Francois Pralong
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

Review 10.  Adipose tissue and adipokines: for better or worse.

Authors:  M Guerre-Millo
Journal:  Diabetes Metab       Date:  2004-02       Impact factor: 6.041

View more
  13 in total

1.  QKI regulates adipose tissue metabolism by acting as a brake on thermogenesis and promoting obesity.

Authors:  Huanyu Lu; Zichen Ye; Yue Zhai; Li Wang; Ying Liu; Jiye Wang; Wenbin Zhang; Wenjing Luo; Zifan Lu; Jingyuan Chen
Journal:  EMBO Rep       Date:  2019-12-23       Impact factor: 8.807

2.  Evaluation of [18F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy.

Authors:  Sanni Tuominen; Thomas Keller; Nataliia Petruk; Francisco López-Picón; Dominik Eichin; Eliisa Löyttyniemi; Alejandra Verhassel; Johan Rajander; Jouko Sandholm; Johanna Tuomela; Tove J Grönroos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-12-19       Impact factor: 9.236

3.  The GTPase Rab37 Participates in the Control of Insulin Exocytosis.

Authors:  Sanda Ljubicic; Paola Bezzi; Saska Brajkovic; Valeria Nesca; Claudiane Guay; Norihiko Ohbayashi; Mitsunori Fukuda; Amar Abderrhamani; Romano Regazzi
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 4.  Decompensation of β-cells in diabetes: when pancreatic β-cells are on ICE(R).

Authors:  Roberto Salvi; Amar Abderrahmani
Journal:  J Diabetes Res       Date:  2014-02-10       Impact factor: 4.011

5.  The class I histone deacetylase inhibitor MS-275 prevents pancreatic beta cell death induced by palmitate.

Authors:  Valérie Plaisance; Laure Rolland; Valéry Gmyr; Jean-Sébastien Annicotte; Julie Kerr-Conte; François Pattou; Amar Abderrahmani
Journal:  J Diabetes Res       Date:  2014-12-31       Impact factor: 4.011

6.  Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function.

Authors:  Julien Bricambert; Dimitri Favre; Saška Brajkovic; Amélie Bonnefond; Raphael Boutry; Roberto Salvi; Valérie Plaisance; Mohamed Chikri; Giulia Chinetti-Gbaguidi; Bart Staels; Vittorio Giusti; Robert Caiazzo; François Pattou; Gérard Waeber; Philippe Froguel; Amar Abderrahmani
Journal:  Mol Metab       Date:  2016-10-05       Impact factor: 7.422

7.  Evidence for tuning adipocytes ICER levels for obesity care.

Authors:  Saška Brajkovic; Raphael Marenzoni; Dimitri Favre; Audrey Guérardel; Roberto Salvi; Nicole Beeler; Philippe Froguel; Peter Vollenweider; Gérard Waeber; Amar Abderrahmani
Journal:  Adipocyte       Date:  2012-07-01       Impact factor: 4.534

8.  Genomic structure of nucleotide diversity among Lyon rat models of metabolic syndrome.

Authors:  Man Chun John Ma; Santosh S Atanur; Timothy J Aitman; Anne E Kwitek
Journal:  BMC Genomics       Date:  2014-03-14       Impact factor: 3.969

9.  Breaking dogma for future therapy using stem cell - Where we have reached?

Authors:  Rama S Verma
Journal:  Indian J Med Res       Date:  2016-02       Impact factor: 2.375

10.  Islet Brain 1 Protects Insulin Producing Cells against Lipotoxicity.

Authors:  Saška Brajkovic; Mourad Ferdaoussi; Valérie Pawlowski; Hélène Ezanno; Valérie Plaisance; Erik Zmuda; Tsonwin Hai; Jean-Sébastien Annicotte; Gérard Waeber; Amar Abderrahmani
Journal:  J Diabetes Res       Date:  2015-11-09       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.